Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes. [electronic resource]
Producer: 20160713Description: 84-90 p. digitalISSN:- 1423-0259
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- adverse effects
- Choroidal Neovascularization -- diagnosis
- Female
- Fluorescein Angiography
- Humans
- Intravitreal Injections
- Male
- Prospective Studies
- Receptors, Vascular Endothelial Growth Factor -- adverse effects
- Recombinant Fusion Proteins -- adverse effects
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.